Washington, D.C.-based Association of Medical Device Reprocessors has filed an amicus brief with the U.S. Supreme Court in support of Charleston, W.Va.-based Impression Products.
Spinal Tech
Mainstay Medical reports progress with ReActiv8 clinical trial in 2016 financial results — 8 updates
Dublin, Ireland-based Mainstay Medical reported its full-year 2016 results.
St. Louis-based Barnes-Jewish Hospital's Washington University Pain Center is offering spinal cord stimulation to treat back pain, sans opioids, according to Medical Xpress.
The North American bone grafts and substitutes market is set to reach $2.1 billion by 2023, according to a GlobalData report.
Dublin, Ireland-based Medtronic announced the pricing of $2 billion-worth of senior notes.
Advertisement
The market for reprocessed medical devices is expected to exceed $5 billion by 2023.
Maple Grove, Minn.-based CVRx President and CEO Namid Yared was named chairman of Washington, D.C.-based AdvaMed's board of directors.
Invibio launched PEEK-OPTIMA™ in 1999 as the world's first implantable PEEK polymer. The implant material is ideal for spinal surgery because PEEK is radiolucent and has a modulus of elasticity close to bone, reducing stress shielding.
Menlo Park, Calif.-based Asterias Biotherapeutics announced the sixth and final patient who was administered AST-OPC1 after complete paralysis has exhibited positive signs following the six month study.
Fibrosis, the creation of dense scar tissue, often occurs around implanted medical devices, which inhibits the devices from performing their intended duties.